Burlington Labs to pay $6.75M in Medicaid settlement | Burlington (Vt.) Free Press
A Burlington, Vt.-based drug laboratory company has agreed to pay $6.75 million to settle claims that it over-billed the Vermont Medicaid program for drug screening services.
FTC joins effort to block release of hospital merger documents | Charleston (W.Va.) Gazette-Mail
The Federal Trade Commission is siding with West Virginia Attorney General Patrick Morrisey's effort to block the release of documents related to the merger of Cabell Huntington Hospital and St. Mary's Medical Center.
Investigators clear 100 NYC hospital criminal probes | New York Daily News
New York City investigators have cleared over 100 criminal probes at city hospitals after many languished for years without ever being reviewed.
Kansas City's next micro-hospital wins approval | Kansas City Business Journal
Despite not knowing the official operator, the Roeland Park City Council on Monday approved the Kansas City area's second micro-hospital.
Rethinking automatic insurance coverage for preventive healthcare | National Public Radio
Three doctors who have led a task force that evaluates preventive medical services say the group's recommendations shouldn't be tied by law to insurance coverage. The former chairmen of the U.S. Preventive Services Task Force say the link between medical recommendations and insurance coverage leads to financial incentives that can corrupt the process and distort people's health care decisions.
Hundreds dropped by home health firm after Massachusetts fraud probe | Boston Globe
After Massachusetts Attorney General Maura Healey's office suspended Medicaid payments to the company, Avenue Homecare Services of Lawrence is dumping hundreds of patients. A recent audit showed Avenue over-billed the state by nearly $4.6 million, although the company disputes that finding.
Implant provides new recovery tool for opioid addiction | Click2Houston
Buprenorphine, used to treat opioid addiction, previously came in a pill or film placed under the tongue. Recently the U.S. Food and Drug Administration approved a matchstick-size implant for the treatment, which goes in the arm, called Probuphine.
States struggle with rising Medicaid drug costs | The Hill
As prescription drug prices continue to rise, states are struggling to find ways to cover the costs to Medicaid, which could mean unwelcome changes for beneficiaries and health plans.
MIT professor unloads on Trump after GOP candidate calls him out | Boston Business Journal
Jonathan Gruber, an MIT economics professor and an architect of Massachusetts health reform and the Affordable Care Act, has been out of the spotlight for months. But Republican presidential candidate Donald Trump just dragged him back into it.
